Company registration number 03497155 (England and Wales)
SMITHS NURSERIES LIMITED
FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
PAGES FOR FILING WITH REGISTRAR
SMITHS NURSERIES LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 6
SMITHS NURSERIES LIMITED
BALANCE SHEET
AS AT
31 DECEMBER 2025
31 December 2025
- 1 -
2025
2024
Notes
£
£
£
£
Fixed assets
Tangible assets
4
236,995
206,492
Current assets
Stocks
5
896,808
889,038
Debtors
6
85,507
54,190
Cash at bank and in hand
467,905
848,793
1,450,220
1,792,021
Creditors: amounts falling due within one year
7
(842,630)
(740,972)
Net current assets
607,590
1,051,049
Total assets less current liabilities
844,585
1,257,541
Provisions for liabilities
(58,013)
(50,227)
Net assets
786,572
1,207,314
Capital and reserves
Called up share capital
9
100
100
Profit and loss reserves
786,472
1,207,214
Total equity
786,572
1,207,314

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The directors of the company have elected not to include a copy of the profit and loss account within the financial statements.true

The financial statements were approved by the board of directors and authorised for issue on 7 September 2026 and are signed on its behalf by:
M L Smith
Director
Company registration number 03497155 (England and Wales)
SMITHS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2025
- 2 -
1
Accounting policies
Company information

Smiths Nurseries Limited is a private company limited by shares incorporated in England and Wales. The registered office is 22 Wycombe End, Beaconsfield, Buckinghamshire, HP9 1NB.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

The financial statements have been prepared under the historical cost convention, modified to include the revaluation of certain financial instruments at fair value. The principal accounting policies adopted are set out below.

1.2
Turnover

Turnover is measured at the fair value of the consideration received or receivable for the sale of goods and the rendering of services in the normal course of business, and is shown net of discounts and VAT.

Revenue from the sale of goods is recognised when the significant risks and rewards of ownership of the goods have passed to the buyer (usually on dispatch of the goods), the amount of revenue can be measured reliably, it is probable that the economic benefits associated with the transaction will flow to the entity and the costs incurred or to be incurred in respect of the transaction can be measured reliably.

1.3
Tangible fixed assets

Tangible fixed assets are initially measured at cost and subsequently measured at cost or valuation, net of depreciation and any impairment losses.

Depreciation is recognised so as to write off the cost or valuation of assets less their residual values over their useful lives on the following bases:

Plant and machinery
25% straight line method
Fixtures, fittings & equipment
25% straight line method
Motor vehicles
25% straight line method

The gain or loss arising on the disposal of an asset is determined as the difference between the sale proceeds and the carrying value of the asset, and is credited or charged to profit or loss.

1.4
Stocks

Stocks are stated at the lower of cost and estimated selling price less costs to complete and sell. Cost comprises direct materials and, where applicable, direct labour costs and those overheads that have been incurred in bringing the stocks to their present location and condition.

At each reporting date, an assessment is made for impairment. Any excess of the carrying amount of stocks over its estimated selling price less costs to complete and sell is recognised as an impairment loss in profit or loss. Reversals of impairment losses are also recognised in profit or loss.

SMITHS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
1
Accounting policies
(Continued)
- 3 -
1.5
Financial instruments

The company has elected to apply the provisions of Section 11 ”Basic financial Instruments” to all of its financial instruments.

 

Financial instruments are recognised in the company’s balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Basic financial assets

Short term debtors are measured at transaction price less any provision for impairment. Loans receivable are measured initially at fair value, net of transaction costs and are subsequently carried at amortised costs using the effective interest method, less any provision for impairment.

Basic financial liabilities

Short term creditors are measured at transaction price. Other financial liabilities, including bank loans and other loans, are measured initially at fair value, net of transaction costs and are subsequently carried at amortised costs using the effective interest method.

1.6
Taxation

The tax expense represents the sum of the tax currently payable and deferred tax.

Current tax

The tax currently payable is based on taxable profit for the year. Taxable profit differs from net profit as reported in the profit and loss account because it excludes items of income or expense that are taxable or deductible in other years and it further excludes items that are never taxable or deductible. The company’s liability for current tax is calculated using tax rates that have been enacted or substantively enacted by the reporting end date.

Deferred tax

Deferred tax liabilities are generally recognised for all timing differences and deferred tax assets are recognised to the extent that it is probable that they will be recovered against the reversal of deferred tax liabilities or other future taxable profits. Such assets and liabilities are not recognised if the timing difference arises from goodwill or from the initial recognition of other assets and liabilities in a transaction that affects neither the tax profit nor the accounting profit.

1.7
Retirement benefits

Payments to defined contribution retirement benefit schemes are charged as an expense as they fall due.

1.8
Leases

Rentals payable under operating leases, including any lease incentives received, are charged to profit or loss on a straight line basis over the term of the relevant lease except where another more systematic basis is more representative of the time pattern in which economic benefits from the leased asset are consumed.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the directors are required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

SMITHS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
2
Judgements and key sources of estimation uncertainty
(Continued)
- 4 -
Key sources of estimation uncertainty

The estimates and assumptions which have a significant risk of causing a material adjustment to the carrying amount of assets and liabilities are as follows.

Valuation of stock

Stock is valued at the lower of cost and net realisable value. Stock is valued from a 3rd party stock take of items held in the main storage locations, where margins are applied to the RRP to estimate the cost. The remaining stock is valued from an internal stock take where margins are applied to the RRP to estimate the cost. Net realisable value includes, where necessary, provisions for slow moving stock. Calculations of these provisions requires estimates to be made, which includes forecast consumer demand and economic environment.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2025
2024
Number
Number
Total
70
72
4
Tangible fixed assets
Plant and machinery
Fixtures, fittings & equipment
Motor vehicles
Total
£
£
£
£
Cost
At 1 January 2025
330,534
545,937
224,851
1,101,322
Additions
-
0
70,679
78,912
149,591
At 31 December 2025
330,534
616,616
303,763
1,250,913
Depreciation and impairment
At 1 January 2025
262,229
473,964
158,637
894,830
Depreciation charged in the year
31,154
43,182
44,752
119,088
At 31 December 2025
293,383
517,146
203,389
1,013,918
Carrying amount
At 31 December 2025
37,151
99,470
100,374
236,995
At 31 December 2024
68,305
71,973
66,214
206,492
5
Stocks
2025
2024
£
£
Stocks
896,808
889,038
SMITHS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 5 -
6
Debtors
2025
2024
Amounts falling due within one year:
£
£
Trade debtors
47,705
9,974
Other debtors
37,802
44,216
85,507
54,190
7
Creditors: amounts falling due within one year
2025
2024
£
£
Trade creditors
149,101
98,803
Amounts owed to group undertakings
424,039
328,368
Taxation and social security
154,391
158,138
Other creditors
115,099
155,663
842,630
740,972

 

8
Deferred taxation

The following are the major deferred tax liabilities and assets recognised by the company and movements thereon:

Liabilities
Liabilities
2025
2024
Balances:
£
£
Accelerated capital allowances
58,477
50,802
Retirement benefit obligations
(464)
(575)
58,013
50,227
2025
Movements in the year:
£
Liability at 1 January 2025
50,227
Charge to profit or loss
7,786
Liability at 31 December 2025
58,013
SMITHS NURSERIES LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2025
- 6 -
9
Called up share capital
2025
2024
Ordinary share capital
£
£
Issued and fully paid
100 Ordinary Shares of £1 each
100
100
10
Operating lease commitments
As lessee

At the reporting end date the company had outstanding commitments for future minimum lease payments under non-cancellable operating leases, as follows:

2025
2024
£
£
Within one year
8,366
-
0
Between two and five years
15,337
-
0
Total commitments
23,703
-
0
11
Audit report information

As the income statement has been omitted from the filing copy of the financial statements, the following information in relation to the audit report on the statutory financial statements is provided in accordance with s444(5B) of the Companies Act 2006.

The auditor's report is unqualified and includes the following:

Senior Statutory Auditor:
Keir Singleton
Statutory Auditor:
S&W Audit
Date of audit report:
8 September 2026
12
Related party transactions

The company has taken advantage of the exemptions permitted by FRS 102 section 1.AC.35 not to provide disclosures of transactions entered into with other wholly-owned members of the group.

13
Parent company

The immediate and ultimate parent company is Smiths Holdings Limited by virtue of its ownership of the company's entire share capital.

The ultimate controlling party is D L Smith and N A Smith by virtue of their ownership of the entire shareholding of Smiths Holdings Limited.

2025-12-312025-01-01falsefalsefalse08 September 2026CCH SoftwareCCH Accounts Production 2025.300No description of principal activityN A SmithD L SmithR L CollinsA L SmithM L SmithD L Smith034971552025-01-012025-12-31034971552025-12-31034971552024-12-3103497155core:PlantMachinery2025-12-3103497155core:FurnitureFittings2025-12-3103497155core:MotorVehicles2025-12-3103497155core:PlantMachinery2024-12-3103497155core:FurnitureFittings2024-12-3103497155core:MotorVehicles2024-12-3103497155core:CurrentFinancialInstrumentscore:WithinOneYear2025-12-3103497155core:CurrentFinancialInstrumentscore:WithinOneYear2024-12-3103497155core:CurrentFinancialInstruments2025-12-3103497155core:CurrentFinancialInstruments2024-12-3103497155core:ShareCapital2025-12-3103497155core:ShareCapital2024-12-3103497155core:RetainedEarningsAccumulatedLosses2025-12-3103497155core:RetainedEarningsAccumulatedLosses2024-12-3103497155core:ShareCapitalOrdinaryShareClass12025-12-3103497155core:ShareCapitalOrdinaryShareClass12024-12-3103497155bus:Director42025-01-012025-12-3103497155core:PlantMachinery2025-01-012025-12-3103497155core:FurnitureFittings2025-01-012025-12-3103497155core:MotorVehicles2025-01-012025-12-31034971552024-01-012024-12-3103497155core:PlantMachinery2024-12-3103497155core:FurnitureFittings2024-12-3103497155core:MotorVehicles2024-12-31034971552024-12-3103497155bus:OrdinaryShareClass12025-01-012025-12-3103497155core:WithinOneYear2025-12-3103497155core:WithinOneYear2024-12-3103497155core:BetweenTwoFiveYears2025-12-3103497155core:BetweenTwoFiveYears2024-12-3103497155bus:PrivateLimitedCompanyLtd2025-01-012025-12-3103497155bus:SmallCompaniesRegimeForAccounts2025-01-012025-12-3103497155bus:FRS1022025-01-012025-12-3103497155bus:Audited2025-01-012025-12-3103497155bus:Director12025-01-012025-12-3103497155bus:Director22025-01-012025-12-3103497155bus:Director32025-01-012025-12-3103497155bus:Director52025-01-012025-12-3103497155bus:CompanySecretary12025-01-012025-12-3103497155bus:FullAccounts2025-01-012025-12-31xbrli:purexbrli:sharesiso4217:GBP